Important Notice for Regeneron Pharmaceuticals Shareholders: Discuss Your Rights Before March 2025

Important News for Regeneron Pharmaceuticals Shareholders

Shareholders of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) are advised to take immediate action regarding their rights and potential claims against the company. The Gross Law Firm has announced a formal notice encouraging investors who purchased shares during the specified period to reach out for guidance and support.

Class Action Overview

The notice pertains particularly to shareholders who bought shares between November 2, 2023, and October 30, 2024. Allegations have surfaced suggesting that Regeneron made misleading statements regarding its business practices, specifically about the pricing and reporting of its flagship product, Eylea.

Allegations against Regeneron Pharmaceuticals

The complaint outlines several key points:
1. Regeneron allegedly paid credit card processing fees to distributors under the condition that they would not charge Eylea customers higher prices for using credit cards.
2. Such payments effectively masked the true cost of Eylea for consumers, thereby altering sales records.
3. As a result, the pricing strategy not only reduced Eylea's selling price but also gave the company a competitive edge in the market.
4. Notably, the complaint asserts that by not reporting these payments accurately, Regeneron misrepresented its Average Selling Price (ASP) to federal authorities, potentially violating the False Claims Act.
5. Overall, these practices have led to inflated perceptions of the company's sales performance and financial health.

Deadline for Action

The deadline for shareholders to register for this class action lawsuit is March 10, 2025. Those who register can monitor the progress of the case and receive updates throughout the legal process without any financial obligation.

Next Steps for Shareholders

To proceed, shareholders should complete their registration through the provided link. Following registration, individuals will be included in a monitoring system that tracks the status of the case. This proactive approach is essential, as it allows investors to stay informed and prepared for any developments.

Why Choose The Gross Law Firm?

The Gross Law Firm specializes in class action lawsuits and is dedicated to defending the rights of investors. They focus on combating fraudulent practices that mislead shareholders and distort a company's stock value. Their commitment extends toward enhancing responsible corporate conduct and ensuring investor protection.

As a recognized entity in the legal landscape, The Gross Law Firm offers shareholders an opportunity to have their voices heard and to seek restitution for any losses incurred due to misleading business practices.